Sageworth Trust’s Halozyme HALO Stock Holding History

Sageworth Trust’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,150	Closed	-$35K	–	222
2019 Q1	$35K	Buy	2,150 +2,100	+4,200%	+$34K	﹤0.01%	103
2018 Q4	$1K	Buy	+50	New	+$798	﹤0.01%	142

Other funds holding HALO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Sageworth Trust's HALO Position: Q2 2019 in Review

Sageworth Trust sold out of Halozyme (HALO) in Q2 2019, closing a stake of 2,150 shares — an estimated $35K sold.

Sageworth Trust first reported a position in HALO in Q4 2018 and held it in 2 quarters. The position peaked at $35K in Q1 2019. 202 funds tracked by Wall St. Rank hold HALO as of Q2 2019.

Sageworth Trust reported no remaining Halozyme position as of Q2 2019 after selling out during the quarter.
Sageworth Trust sold 2,150 Halozyme shares in Q2 2019, an estimated $35K.
Sageworth Trust first reported a position in Halozyme in Q4 2018 and held it in 2 quarters.
Sageworth Trust's Halozyme position peaked at $35K in Q1 2019.
202 funds tracked by Wall St. Rank held Halozyme as of Q2 2019.

Based on Sageworth Trust's 13F filing for Q2 2019, filed 19 Jul 2019.